Company UCB

Equities

UCB

BE0003739530

Pharmaceuticals

Real-time Euronext Bruxelles 12:35:05 2024-03-28 pm EDT 5-day change 1st Jan Change
114.4 EUR +0.57% Intraday chart for UCB +2.37% +44.99%

Business Summary

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Number of employees: 8,767

Sales per Business

EUR in Million2022Weight2023Weight Delta
Biopharmaceuticals
100.0 %
5,140 100.0 % 4,867 100.0 % -5.31%

Sales per region

EUR in Million2022Weight2023Weight Delta
United States
50.4 %
2,902 56.5 % 2,454 50.4 % -15.44%
Other Countries
11.4 %
507 9.9 % 554 11.4 % +9.27%
Europe - Other
7.5 %
348 6.8 % 365 7.5 % +4.89%
Germany
6.4 %
330 6.4 % 310 6.4 % -6.06%
Japan
5.5 %
324 6.3 % 269 5.5 % -16.98%
Spain
4.6 %
213 4.1 % 224 4.6 % +5.16%
France (including French Territories)
3.3 %
169 3.3 % 162 3.3 % -4.14%
China
3.1 %
159 3.1 % 151 3.1 % -5.03%
Italy
2.9 %
154 3.0 % 143 2.9 % -7.14%
United Kingdom and Ireland
2.7 %
151 2.9 % 133 2.7 % -11.92%
Belgium
1.1 %
49 1.0 % 52 1.1 % +6.12%
Global
1.0 %
-167 -3.2 % 50 1.0 % -129.94%

Managers

Managers TitleAgeSince
Chief Executive Officer 65 11-05-31
Director of Finance/CFO 57 20-06-30
Chief Tech/Sci/R&D Officer 63 17-09-30
Chief Tech/Sci/R&D Officer 65 18-12-31
Chief Tech/Sci/R&D Officer 63 06-08-31
Investor Relations Contact - -
Corporate Officer/Principal - -
Comptroller/Controller/Auditor - -
Human Resources Officer 59 17-08-31
Corporate Officer/Principal - 94-02-28

Members of the board

Members of the board TitleAgeSince
Director/Board Member 66 16-04-27
Director/Board Member 73 13-12-31
Director/Board Member 69 10-04-28
Chief Executive Officer 65 11-05-31
Director/Board Member 53 14-12-31
Chairman 66 20-12-31
Director/Board Member 58 22-12-31
Director/Board Member 54 14-04-23
Director/Board Member 53 00-12-31
Director/Board Member 69 20-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 194,505,658 119,471,332 ( 61.42 %) 4,755,075 ( 2.445 %) 61.42 %

Shareholders

NameEquities%Valuation
69,440,861 35.70 % 8 003 M €
Wellington Management Co. LLP
6.555 %
12,749,947 6.555 % 1 469 M €
UCB
2.525 %
4,910,760 2.525 % 566 M €
BNP Paribas Asset Management Belgium SA
0.8535 %
1,660,111 0.8535 % 191 M €
FMR Investment Management (UK) Ltd.
0.4942 %
961,341 0.4942 % 111 M €
Amundi Asset Management SA (Investment Management)
0.4404 %
856,660 0.4404 % 99 M €
Wellington Management International Ltd.
0.4274 %
831,398 0.4274 % 96 M €
State Street Global Advisors Ltd.
0.4210 %
818,919 0.4210 % 94 M €
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.2527 %
491,558 0.2527 % 57 M €
Mackenzie Investments Europe Ltd.
0.2496 %
485,503 0.2496 % 56 M €
NameEquities%Valuation
RhumbLine Advisers LP
0.000663 %
2,580 0.000663 % 148 670 €
GAMMA Investing LLC
0.000020 %
78 0.000020 % 4 495 €

Holdings

NameEquities%Valuation
UCB
2.52%
4,910,760 2.52% 565,960,081 $
5,647,679 4.36% 10,171,809 $
1,131,186 2.43% 3,745,787 $

Company contact information

UCB SA

Allée de la Recherche, 60

1070, Brussels

+32 2 559 99 99

http://www.ucb.com
address UCB(UCB)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
UCB Manufacturing Ireland Ltd.
Financial Conglomerates
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Medical Distributors
UCB Ventures Belgium SA
Investment Managers